Tyrus Capital S.A.M. AVIR Holdings History
Tyrus Capital S.A.M.'s Atea Pharmaceuticals Inc Holding Summary
As of 2023-09-30, Tyrus Capital S.A.M. held 1.26 Mil shares of Atea Pharmaceuticals Inc(AVIR), totaling $3.78 Mil. This investment constitutes 35.9% of their stock portfolio, and Tyrus Capital S.A.M. now holds 1.51% of the outstanding Atea Pharmaceuticals Inc(AVIR) stock.
The initial trade took place in 2022Q4. And since then Tyrus Capital S.A.M. has made 1 purchases of AVIR, at an average price of $5.06, for a total of 1.26 Mil shares. Based on historical transaction data and AVIR's current price of $3.53, Tyrus Capital S.A.M.'s estimated gain on his AVIR holdings is $-1.93 Mil, reflecting a -30.24% gain to date.
Tyrus Capital S.A.M. AVIR ($3.53) Holding Chart
Tyrus Capital S.A.M. AVIR ($3.53) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
